Intravenous infusion of saline

DRUG2 trials

Sponsors

University Hospital, Linkoeping, University Hospital, Gentofte, Copenhagen

Conditions

Coronary Artery BypassCoronary Artery DiseaseMyocardial InfarctionMyocardial IschemiaPostPrandial Hypotension

Phase 3

Glutamate for Metabolic Intervention in Coronary Surgery

CompletedNCT00489827

University Hospital, LinkoepingCoronary Artery Bypass, Coronary Artery Disease, Myocardial Infarction +1

Start: 2005-10-31End: 2022-08-31Updated: 2024-05-22

Unknown Phase

The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension

Enrolling by invitationNCT06208904

University Hospital, Gentofte, CopenhagenPostPrandial Hypotension

Start: 2024-05-15End: 2025-12-31Target: 18Updated: 2025-03-14

Related Papers

Association of Glutamate Infusion With Risk of Acute Kidney Injury After Coronary Artery Bypass Surgery

JAMA Network Open2024-01-2212 citations

Utility of NT-proBNP as an objective marker of postoperative heart failure after coronary artery bypass surgery: a prospective observational study.

2021-07-133 citations

The impact of glutamate infusion on postoperative NT-proBNP in patients undergoing coronary artery bypass surgery: a randomized study.

2020-05-116 citations

Post hoc analysis of the glutamics-trial: intravenous glutamate infusion and use of inotropic drugs after cabg.

2016-08-024 citations

EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery.

2014-04-1131 citations